GenoSpace, PathGroup, Thomson Reuters Collaborate on Personalized Medicine for Oncology | GenomeWeb

NEW YORK (GenomeWeb News) – GenoSpace, PathGroup, and Thomson Reuters' IP & Science business today announced an initiative aimed at personalized medicine in oncology.

The partners will combine their resources, technologies, and expertise to integrate PathGroup's SmartGenomics next generation DNA sequencing and cytogenomic array with traditional pathology assays, enabling genetic profiling that may lead to greater insights into disease and patient treatment options, they said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.